Clinical ResearchHeart Rhythm DisordersA New Risk Scheme to Predict Warfarin-Associated Hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study

By M. Fang, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, N. Pomernacki, N. Udaltsova, D. Singer. 2011

883 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology, Surgery

View Paper: https://www.semanticscholar.org/paper/316b57855328a26307436767db9d72aaf6c34695

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerhard Hindricks
2. Gregory Y. H. Lip
3. Cynthia Rudin

Citations in the corpus

• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “Derived from the ATRIA score.(385) Derived from the ORBIT score.”
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012, background): “), Drugs/alcohol concomitantly],(54) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation).(55) The 2010 ESC Guidelines on AF,(1) Canadian Cardiovascular Society Guidelines (recently updated).”
• Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012, background): “The number of risk factors included in the bleeding risk schemas varies considerably, from three(100) to 12,(102) and the score or weighting associated with each risk factor also differs (Table 3).(69,98-103)”